image of Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition): 2024 Drug Supplement

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition): 2024 Drug Supplement

Publication Year:
2025
Edition:
2024
Author:
Mikaela Olsen; Kristine B. Lefebvre; Suzanne L. Walker, et al.
Publisher:
The Oncology Nursing Society
ISBN:
978-1-63-593070-2
Print/PDF
Request Info
Add to Ovid Subscription
Access the Book in Ovid
Access the Book in Ovid
  • Description
  • Details
  • Collections
  • Also Recommended
Description

Significant advancements in cancer care have made this an exciting time to work in the oncology specialty, and it is critical that healthcare professionals have access to the most current information on cancer research.

The Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition): 2024 Drug Supplement is an up-to-date resource on the latest U.S. Food and Drug Administration (FDA)-approved antineoplastic agents from September 2021 through May 2024. 
The 2024 Drug Supplement includes more than 30 new antineoplastic agents approved by FDA and their indications, mechanism of action, side effects, and nursing considerations. The information is organized in a user-friendly format for quick reference and is available in a digital format for easy access.
Details
Platform:
OvidSP
Publisher:
The Oncology Nursing Society
Product Type:
Book
Author:
Mikaela Olsen; Kristine B. Lefebvre; Suzanne L. Walker, et al.
ISBN:
978-1-63-593070-2
Specialty:
  • Internal Medicine
  • Oncology
  • Pharmacology
Language:
English
Edition:
2024
Pages:
43
Publication Year:
2025

Request Information

Rely on Ovid as the trusted solution that transforms research into results.
Back To Top